Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis

15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...

Read more →

PBAC goes PC

20 December 2019 - PBAC responds to a minor submission from National Aboriginal Community Controlled Health Organisation. ...

Read more →

Aerie Pharmaceuticals announces acceptance for review of the Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% marketing authorisation application in Europe

2 January 2020 - Aerie Pharmaceuticals today announced that the EMA has accepted for review the marketing authorisation application for Roclanda ...

Read more →

AstraZeneca’s triple-combination therapy approved in China for patients with COPD

23 December 2019 - First fixed-dose triple-combination therapy in a pressurised metered-dose inhaler device in China. ...

Read more →

ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV

21 December 2019 - ViiV Healthcare, with Pfizer and Shionogi, has received a complete response letter from the US FDA regarding ...

Read more →

Decision to award sole supply for fluticasone and fluticasone with salmeterol metered dose inhalers

12 December 2019 - PHARMAC has made a decision to make changes to the funded brands of fluticasone and fluticasone ...

Read more →

Pickering mom fights for life-changing CF medicine to come to Canada

10 December 2019 - Stephanie Stavros feels like she's 'screaming into an abyss' as her life slips away. ...

Read more →

Health Canada grants priority review status for Heron Therapeutics' new drug submission for HTX-011 for management of post-operative pain

3 December 2019 - Heron Therapeutics today announced that Heron's new drug submission for HTX-011 for the management of postoperative pain ...

Read more →

Aerie Pharmaceuticals submits marketing authorisation application for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in Europe

3 December 2019 - Aerie Pharmaceuticals today announced that it has submitted the marketing authorisation application for Roclanda (netarsudil and latanoprost ...

Read more →

Tasmanian man Robert Mitchell welcomes rollout of new drug Dovato on PBS

2 December 2019 - Robert Mitchell has been defying a medical diagnosis for nearly 30 years. Now a new drug will ...

Read more →

Sosei Heptares announces that the COPD treatment Ultibro Breezhaler has been included in the National Reimbursement Drug List in China

28 November 2019 - Sosei Group announces that Ultibro Breezhaler (an inhaled once-daily fixed-dose combination of indacaterol/glycopyrronium bromide) has been included ...

Read more →

Hikma completes its FDA response for generic Advair

27 November 2019 - Hikma Pharmaceuticals today announces that it has submitted to the US FDA its response to deficiencies in ...

Read more →

World AIDS Day 1 December 2019 – more support for Australians living with HIV

27 November 2019 - World AIDS Day is held on 1 December each year. It raises awareness across the world and ...

Read more →

Canberra to increase HIV funding, list groundbreaking drug treatment

27 November 2019 - Australia's bid to be among the first countries in the world to eliminate HIV transmissions will ...

Read more →

Health Canada approves Lonsurf (trifluridine/tipiracil) for adults with metastatic gastric cancer during stomach cancer awareness month

21 November 2019 - New indication improves overall survival for end stage metastatic disease ...

Read more →